CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 162 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Metoclopramide 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04799015
NCT04799015Phase 4Completed
CompareCT.gov

A Randomized Study of Dexamethasone as Adjuvant Therapy for Acute Post-traumatic Headache

Montefiore Medical Center·interventional·Posted Mar 16, 2021·Updated May 15, 2026

In Brief

A Phase 4 clinical trial evaluating Dexamethasone and Metoclopramide 10mg for Post-Traumatic Headache. Completed, enrolled 162 participants across 1 site.

Detailed Summary

This is a randomized study of intravenous metoclopramide + intravenous dexamethasone versus intravenous metoclopramide for patients with acute post-traumatic headache.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-Traumatic Headache
CountriesUnited States
CollaboratorsNational Center for Advancing Translational Sciences (NCATS)

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedMar 16, 2021
Enrollment StartJun 25, 2021
Primary CompletionNov 17, 2024
Study CompletionDec 22, 2024
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 5.3 years ago

Interventions

Dexamethasonedrug

Dexamethasone 10mg IV

Metoclopramide 10mgdrug

Metoclopramide 10mg IV